or Try an Advanced Search...

    Technical Analysis for APVO - Aptevo Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 0.25 -8.15% -0.02
    APVO closed down 8.15 percent on Friday, November 1, 2024, on 12 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Flat Down
    Historical APVO trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    50 DMA Support Bullish -8.15%
    Boomer Buy Setup Bullish Swing Setup -8.15%
    Wide Bands Range Expansion -8.15%
    50 DMA Support Bullish -11.37%
    Calm After Storm Range Contraction -11.37%
    Older End-of-Day Signals for APVO ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 1 day ago
    Fell Below 50 DMA 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Down 5% 1 day ago
    Down 3% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    APVO Chart by TradingView
    Basic chart:

    Profile

    Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Hematology

    Is APVO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Sep 18 Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
    Sep 17 Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Sep 17 Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
    Sep 16 Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study
    Sep 13 Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024
    Aug 30 Aptevo Therapeutics files to sell 13.51M shares of common stock
    Aug 8 Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update
    Jul 18 Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
    See more APVO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.6204
    52 Week Low 0.138
    Average Volume 7,756,957
    200-Day Moving Average 1.97
    50-Day Moving Average 0.25
    20-Day Moving Average 0.21
    10-Day Moving Average 0.27
    Average True Range 0.06
    RSI (14) 52.15
    ADX 53.36
    +DI 35.51
    -DI 9.77
    Chandelier Exit (Long, 3 ATRs) 0.35
    Chandelier Exit (Short, 3 ATRs) 0.30
    Upper Bollinger Bands 0.34
    Lower Bollinger Band 0.09
    Percent B (%b) 0.64
    BandWidth 117.58
    MACD Line 0.01
    MACD Signal Line 0.00
    MACD Histogram 0.0098
    Fundamentals Value
    Market Cap 5.54 Million
    Num Shares 22.3 Million
    EPS -2.44
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 1.61
    Price-to-Book 0.24
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.29
    Resistance 3 (R3) 0.29 0.28 0.28
    Resistance 2 (R2) 0.28 0.27 0.28 0.28
    Resistance 1 (R1) 0.26 0.26 0.26 0.26 0.27
    Pivot Point 0.25 0.25 0.25 0.25 0.25
    Support 1 (S1) 0.24 0.24 0.23 0.24 0.22
    Support 2 (S2) 0.23 0.24 0.23 0.22
    Support 3 (S3) 0.21 0.23 0.22
    Support 4 (S4) 0.21